(±) Epibatidine increases acetylcholine release partly through an action on mascarinic receptors

Basic and Clinical Pharmacology and Toxicology

Volumn 94, Issue 5, 2004, Pages 238-244

  Kommalage, Mahinda ^a   Höglund, A Urban ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATROPINE; EPIBATIDINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; NEOSTIGMINE; NICOTINIC RECEPTOR; ANALGESIC AGENT; FUSED HETEROCYCLIC RINGS; MUSCARINIC AGENT; NICOTINIC AGENT; PYRIDINE DERIVATIVE; TRITIUM;

ACETYLCHOLINE RELEASE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; INSECT CELL; MALE; MICRODIALYSIS; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; SPINAL CORD; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; INSECTA;

ACETYLCHOLINE; ANALGESICS, NON-NARCOTIC; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; MUSCARINIC AGONISTS; NICOTINIC AGONISTS; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SPINAL CORD; TRANSFECTION; TRITIUM;

EID: 2442638820     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.pto940507.x     Document Type: Article

References (52)

1. Abelson, K. S. & A. U. Höglund: Intravenously administered lidocaine in therapeutic doses increases the intraspinal release of acetylcholine in rats. Neurosci. Lett. 2002, 317, 93-96.
2. Abelson, K. S. & A. U. Höglund: Intravenously administered oxotremorine and atropine, in doses known to affect pain threshold, affect the intraspinal release of acetylcholine in rats. Pharmacology & Toxicology 2002, 90, 187-192.
3. Aceto, M. D., R. S. Bagley, W. L. Dewey, T. C. Fu & B. R. Martin: The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology 1986, 25, 1031-1036.
4. Alkondon, M. & E. X. Albuquerque: Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J. Pharmacol. Exp. Therap. 1995, 274, 771-782.
5. Armitage, A. K., A. S. Milton & C. F. Morrison: Effects of nicotine and some nicotine-like compounds injected into the cerebral ventricles of the cat. Brit. J. Pharmac. Chemother 1966, 27, 33-45.
6. Badio, B. & J. W. Daly: Epibatidine, a potent analgetic and nicotinic agonist. Mol. Pharmacol. 1994, 45, 563-569.
7. Bannon, A. W., K. L. Gunther & M. W. Decker: Is epibatidine really analgesic? Dissociation of the activity, temperature, and analgesic effects of (±)-epibatidine. Pharmacol. Biochem. Behav. 1995, 51, 693-698.
8. Billard, W., H. Binch, G. Crosby & R. D. McQuade: Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data. J. Pharmacol. Exp. Therap. 1995, 273, 273-279.
9. Bonhaus, D. W., K. R. Bley, C. A. Broka, D. J. Fontana, E. Leung, R. Lewis, A. Shieh & E. H. Wong: Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J. Pharmacol. Exp. Therap. 1995, 272, 1199-1203.
10. Bouaziz, H., C. Tong & J. C. Eisenach: Postoperative analgesia from intrathecal neostigmine in sheep. Anesth. Analg. 1995, 80, 1140-1144.
11. Cheng, Y. C. & W. H. Prusoff: Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
12. Cordero-Erausquin, M. & J. Changeux: Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc. Natl. Acad. Sci. USA 2001, 98, 2803-2807.
13. Damaj, M. I., M. Fei-Yin, M. Dukat, R. A. Glennon & B. R. Martin: Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J. Pharmacol. Exp. Therap. 1998, 284, 1058-1065.
14. Detweiler, D. J., J. C. Eisenach, C. Tong & C. Jackson: A cholinergic interaction in alphas adrenoceptor-mediated antinociception in sheep. J. Pharmacol. Exp. Therap. 1993, 265, 536-542.
15. Duttaroy, A., J. Gomeza, J. W. Gan, N. Siddiqui, A. S. Basile, W. D. Harman, P. L. Smith, C. C. Felder, A. L. Levey, & J. Wess: Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol. Pharmacol. 2002, 62, 1084-1093.
16. 4 receptor subtype. J. Pharmacol. Exp. Therap. 1999, 288, 1143-1150.
17. Erkman, L., J. Matter, L. Matter-Sadzinski & M. Ballivet: Nicotinic acetylcholine receptor gene expression in developing chick autonomic ganglia. Eur. J. Pharmacol. 2000, 393, 97-104.
18. Genzen, J. R., W. Van Cleve & D. S. McGehee: Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J. Neurophysiol. 2001, 86, 1773-1782.
19. Ghelardini, C., P. Malmberg-Aiello, A. Giotti, M. Malcangio & A. Bartolini: Investigation into atropine-induced antinociception. Brit. J. Pharmacol. 1990, 101, 49-54.
20. Gillberg, P. G., H. Askmark & S. M. Aquilonius: Spinal cholinergic mechanisms. Prog. Brain Res. 1990, 84, 361-370.
21. Gower, A. J.: Effects of acetylcholine agonists and antagonists on yawning and analgesia in the rat. Eur. J. Pharmacol. 1987, 139, 79-89.
22. Hama, A. T., G. K. Lloyd & F. Menzaghi: The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats. Pain 2001, 91, 131-138.
23. Hartvig, P., P. G. Gillberg, T. Gordh, Jr. & C. Post: Cholinergic mechanisms in pain and analgesia. Trends Pharmacol. Sci. 1989, Suppl, 75-79.
24. Höglund, A. U. & H. A. Baghdoyan: M2, M3, and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord. J. Pharmacol. Exp. Therap. 1997, 281, 470-477.
25. Höglund, A. U., C. Hamilton & L. Lindblom: Effects of microdialyzed oxotremorine, carbachol, epibatidine, and scopolamine on intraspinal release of acetylcholine in the rat. J. Pharmacol. Exp. Therap. 2000, 295, 100-104.
26. Iwamoto, E. T.: Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions. J. Pharmacol. Exp. Therap. 1989, 251, 412-421.
27. Iwamoto, E. T. & L. Marion: Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats. J. Pharmacol. Exp. Therap. 1993a, 265, 777-789.
28. Iwamoto, E. T. & L. Marion: Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Therap. 1993b, 266, 329-338.
29. Jinks, S. L. & E. Carstens: Activation of spinal wide dynamic range neurons by intracutaneous microinjection of nicotine. J. Neurophysiol. 1999, 82, 3046-3055.
30. Khan, I. M., H. Buerkle, P. Taylor & T. L. Yaksh: Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology 1998, 37, 1515-1525.
31. Khan, I. M., M. Marsala, M. P. Printz, P. Taylor & T. L. Yaksh: Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J. Pharmacol. Exp. Therap. 1996, 278, 97-106.
32. Khan, I. M., S. Stanislaus, L. Zhang, P. Taylor & T. L. Yaksh: A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception. J. Pharmacol. Exp. Therap. 2001, 297, 230-239.
33. Khan, I. M., T. L. Yaksh & P. Taylor: Epibatidine binding sites and activity in the spinal cord. Brain Res. 1997, 753, 269-282.
34. Kukkonen, J., J. Näsman, P. Ojala, C. Oker-Blom & K. E. O. Åkerman: Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system. J. Pharmacol. Exp. Therap. 1996, 279, 9703-9708.
35. Lawand, N. B., Y. Lu & K. N. Westlund: Nicotinic cholinergic receptors: potential targets for inflammatory pain relief. Pain 1999, 80, 291-299.
36. Liu, L., W. Pugh, H. Ma & S. A. Simon: Identification of acetylcholine receptors in adult rat trigeminal ganglion neurons. Brain Res. 1993, 617, 37-42.
37. Machelska, M., F. Pavone, F. Capone & B. Przewlocka: Antinocicepiton after both peripheral and intrathecal injection of oxotremorine is modulated by spinal nitic oxide. Eur. Neuropsychopharm. 1999, 9, 213-217.
38. Marks, M. J., K. W. Smith & A. C. Collins: Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J. Pharmacol. Exp. Therap. 1998, 285, 377-386.
39. Naguib, M. & T. L. Yaksh: Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth. Analg. 1997, 85, 847-853.
40. Qian, C., T. Li, T. Y. Shen, L. Libertine-Garahan, J. Eckman, T. Biftu & S. Ip: Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 1993, 250, R13-R14.
41. Roth, M. T., M. A. Fleegal, R. Lydic & H. A. Baghdoyan: Pontine acetylcholine release is regulated by muscarinic autoreceptors. Neuroreport 1996, 7, 3069-3072.
42. Rueter, L. E., M. D. Meyer & M. W. Decker: Spinal mechanisms underlying A-85380-induced effects on acute thermal pain. Brain Res. 2000, 872, 93-101.
43. Rupniak, N. M., S. Patel, R. Marwood, J. Webb, J. R. Traynor, J. Elliott, S. B. Freedman, S. R. Fletcher & R. G. Hill: Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity. Brit. J. Pharmacol. 1994, 113, 1487-1493.
44. Sahley, T. L. & G. G. Berntson: Antinociceptive effects of central and systemic administrations of nicotine in the rat. Psychopharmacology (Berl.) 1979, 65, 279-283.
45. Spande, T. F., H. M. Garraffo, M. W. Edward, H. J. C. Yeh, L. Pannel & J. W. Daly: Epibatidine: A novel (chloropyridyl)azabicycloheptane with potent anagesic activity from an Ecuadoran poison frog. J. Amer. Chem. Soc. 1992, 114, 3475-3478.
46. Steen, K. H. & P. W. Reeh: Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro. J. Neurophysiol. 1993, 70, 397-405.
47. Sucher, N. J., T. P. Cheng & S. A. Lipton: Neural nicotinic acetylcholine responses in sensory neurons from postnatal rat. Brain Res. 1990, 533, 248-254.
48. Sullivan, J. P., M. W. Decker, J. D. Brioni, D. Donnelly Roberts, D. J. Anderson, A. W. Bannon, C. H. Kang, P. Adams, M. Piattoni Kaplan, M. J. Buckley, M. Gopalakrishnan, M. Williams & S. P. Arneric: (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Therap. 1994, 271, 624-631.
49. Tripathi, H. L., B. R. Martin & M. D. Aceto: Nicotine-induced antinociception in rats and mice: Correlation with nicotine brain levels. J. Pharmacol. Exp. Therap. 1982, 221, 91-96.
50. Xu, Z., C. Tong, H. L. Pan, S. E. Cerda & J. C. Eisenach: Intravenous morphine increases release of nitric oxide from spinal cord by an α-adrenergic and cholinergic mechanism. J. Neurophysiol. 1997, 78, 2072-2078.
51. Yaksh, T. L., R. Dirksen & G. J. Harty: Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol. 1985, 117, 81-88.
52. Zhuo, M. & G. F. Gebhart: Tonic cholinergic inhibition of spinal mechanical transmission. Pain 1991, 46, 211-222.